Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Biotech
Lexeo acquires Mantle for $8M, adding Friedreich ataxia assets
Lexeo has agreed to acquire Mantle Therapeutics via an upfront payment of $8.3 million while locking in three strategic collaborations.
Will Maddox
Sep 22, 2026 9:58am
Newly formed Jaguar acquires Afib device assets from J&J
Sep 15, 2026 11:11am
Fierce Pharma
Novartis investor calls for board overhaul after costly setbacks
Sep 10, 2026 10:26am
Fortrea boosts early-phase platform with $45M acquisition
Sep 2, 2026 3:06pm
Skye and Redx combine with $125M to advance fibrosis assets
Aug 14, 2026 2:05pm
Jazz pays $820M to add epilepsy-focused Actio to its orchestra
Aug 10, 2026 10:40am